Shree Ganesh Remedies: Financial Results for quarter and half year ended September 30, 2026
Shree Ganesh Remedies (SGRL) filed a disclosure titled "Financial Results for quarter and half year ended September 30, 2026". The company is valued at about ₹792 crore.
What happened
Shree Ganesh Remedies (SGRL) filed a disclosure with the exchanges on 31 October 2026 at 07:35 PM titled "Financial Results for quarter and half year ended September 30, 2026".
Company snapshot
Shree Ganesh Remedies is a micro-cap company, with a market value of about ₹792 crore.
The stock last traded at ₹617.3, against a 52-week range of ₹490–₹749.9 (17.7% below the high).
Before this filing the shares had moved −7.3% over the month. Average daily turnover over the last 20 sessions was about ₹0.7 crore.
Promoters held 72.84% at the end of Q1 FY27.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 25 | 3.5 | 2.69 |
| Q2 FY26 | 30 | 5 | 3.86 |
| Q3 FY26 | 21 | 3.1 | 2.41 |
| Q4 FY26 | 33 | 6.3 | 4.88 |
| Q1 FY27 | 14 | 1.1 | 0.87 |
What history shows
BCEIE has no earlier results filing from this company on record since May 2026.
Market-wide, 10,125 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.